Cargando…

499. Immunotherapy with Pattern Recognition Receptor Agonists Improves Morbidity and Mortality in a Corticosteroid-Immunosuppressed Murine Model of Influenza-Associated Pulmonary Aspergillosis

BACKGROUND: Corticosteroids are known to increase the incidence and worsen the outcomes of influenza-associated pulmonary aspergillosis (IAPA) in patients with severe influenza pneumonia. Adjunct immunomodulatory strategies might improve the treatment of this emerging entity, but in-vivo data in val...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wurster, Sebastian, García, Jezreel Pantaleón, Albert, Nathaniel D, Evans, Scott, Kontoyiannis, Dimiitrios P
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752376/ http://dx.doi.org/10.1093/ofid/ofac492.556

Ejemplares similares

124. Establishment of a Post-Influenza Aspergillosis Model in Corticosteroid-Immunosuppressed Mice
por: Wurster, Sebastian, et al.
Publicado: (2021)

974. PD-1 Immune Checkpoint Blockade Improves Survival and Promotes Fungal Clearance in an Immunosuppressed Murine Invasive Pulmonary Aspergillosis (IPA) Model
por: Wurster, Sebastian, et al.
Publicado: (2019)

Diol-Based Polymer Microparticles for Treatment of Cutaneous Aspergillosis in an Immunocompromised Murine Model
por: Tatara, Alexander, et al.
Publicado: (2017)

482. The modern face of esophageal candidiasis (EC) in an oncology center: Analysis of 323 cancer patients with EC
por: Matsuo, Takahiro, et al.
Publicado: (2022)

2102. Common co-occurence in the respiratory tract of Mucorales with Gram-negative rods in patients with hematologic malignancy and sinopulmonary mucormycosis
por: Egge, Stephanie L, et al.
Publicado: (2022)

2114. Invasive fusariosis in the era of mold active azoles and molecular targeted chemotherapy: Increasing incidence and lack of improved outcomes
por: Matsuo, Takahiro, et al.
Publicado: (2022)

828. Do lung co-infections influence outcome in patients with hematological malignancies and culture-documented invasive pulmonary aspergillosis?
por: Matsuo, Takahiro, et al.
Publicado: (2023)

Checkpoint inhibitors as immunotherapy for fungal infections: Promises, challenges, and unanswered questions
por: Wurster, Sebastian, et al.
Publicado: (2022)

THU499 The Mesenchymal Stem Cells Induce Immunosuppressive Microenvironment In Pituitary Tumors
por: Marrero-Rodríguez, Daniel, et al.
Publicado: (2023)

465. A Multifaceted and Multi-Institutional Analysis of the COVID19-Associated Mucormycosis Outbreak in the Delhi Area Indicates the Simultaneous Convergence of Multiple Risk Factors
por: Chowdhary, Anuradha, et al.
Publicado: (2022)

COVID-19 patients share common, corticosteroid-independent features of impaired host immunity to pathogenic molds
por: Tappe, Beeke, et al.
Publicado: (2022)

Candida auris Bloodstream Infection Induces Upregulation of the PD-1/PD-L1 Immune Checkpoint Pathway in an Immunocompetent Mouse Model
por: Wurster, Sebastian, et al.
Publicado: (2022)

Receiver operating characteristic analysis: an ally in the pandemic
por: García, Jezreel Pantaleón, et al.
Publicado: (2021)

Corticosteroid-Induced Immunosuppression Ultimately Does Not Compromise the Efficacy of Antibiotherapy in Murine Mycobacterium ulcerans Infection
por: Martins, Teresa G., et al.
Publicado: (2012)

Poster Sessions 499–563
Publicado: (2001)

Dupilumab: a new contestant to corticosteroid in allergic bronchopulmonary aspergillosis
por: Ali, Muhammad, et al.
Publicado: (2021)

The association between corticosteroids and aspergillosis among COVID-19 patients
por: Chang, Yi-Hsin, et al.
Publicado: (2023)

Blockade of the PD-1/PD-L1 Immune Checkpoint Pathway Improves Infection Outcomes and Enhances Fungicidal Host Defense in a Murine Model of Invasive Pulmonary Mucormycosis
por: Wurster, Sebastian, et al.
Publicado: (2022)

Reply to Yasuma et al.: Response of Lung Microbiota to Changes of Pulmonary Innate Immunity under Healthy Conditions
por: Pantaleón García, Jezreel, et al.
Publicado: (2021)

Factors affecting patient outcome in primary cutaneous aspergillosis
por: Tatara, Alexander M., et al.
Publicado: (2016)

Therapeutic effects of pentoxifylline on invasive pulmonary aspergillosis in immunosuppressed mice
por: Feng, Chunlai, et al.
Publicado: (2021)

Disseminated aspergillosis in an immunocompetent patient treated with corticosteroids: value of PCR for diagnosis
por: Guirao-Arrabal, Emilio, et al.
Publicado: (2019)

499 Visiting Scholars in Times of Pandemic
por: Moussatche, Patricia, et al.
Publicado: (2022)

P499 A cross-sectional observational to assess the role of Bronchoalveolar lavage fluid galactomannan in the diagnosis of invasive pulmonary aspergillosis in non-neutropenic patients
por: Nomula, Gowtham Reddy, et al.
Publicado: (2022)

Semi-invasive pulmonary aspergillosis in an immunosuppressed patient: a case report
por: Cabral, Fernanda C, et al.
Publicado: (2009)

Invasive Pulmonary Aspergillosis: Not Only a Disease Affecting Immunosuppressed Patients
por: Zaragoza, Rafael, et al.
Publicado: (2023)

Cancer immunotherapy by immunosuppression
por: Prehn, Richmond T, et al.
Publicado: (2010)

Inducible lung epithelial resistance requires multisource reactive oxygen species generation to protect against bacterial infections
por: Ware, Hayden H., et al.
Publicado: (2019)

Corticosteroids/immunosuppressants: Coronavirus disease 2019: case report
Publicado: (2020)

Long‐Term Corticosteroid‐Sparing Immunosuppression for Cardiac Sarcoidosis
por: Rosenthal, David G., et al.
Publicado: (2019)

SAT-499 Denosumab for Treatment of Hypercalcemia in Myelofibrosis
por: Wong, Beatrice, et al.
Publicado: (2019)

CNS aspergillosis in a patient with Crohn’s disease on immunosuppressants: a case report
por: Shah, Shreyansh, et al.
Publicado: (2009)

Corticosteroids as risk factor for COVID-19-associated pulmonary aspergillosis in intensive care patients
por: Leistner, Rasmus, et al.
Publicado: (2022)

Role of the immunosuppressive microenvironment in immunotherapy
por: Tormoen, Garth W., et al.
Publicado: (2018)

The Immunotherapy and Immunosuppressive Signaling in Therapy-Resistant Prostate Cancer
por: Xu, Pengfei, et al.
Publicado: (2022)

Immunosuppressant Agents in the Treatment of Glomerulonephritis: Part 1. Corticosteroid Drugs
por: Cameron, J. S.
Publicado: (1971)

Corticosteroid and Immunosuppressant Therapy for Cardiac Sarcoidosis: A Systematic Review
por: Fazelpour, Siavosh, et al.
Publicado: (2021)

Cardiac sarcoidosis: systematic review of the literature on corticosteroid and immunosuppressive therapies
por: Stievenart, Julien, et al.
Publicado: (2022)

355. Invasive Pulmonary Aspergillosis (IPA) Complicating Respiratory Viral Infections in Patients With Hematological Malignancies
por: Magira, Eleni, et al.
Publicado: (2018)

SAT499 Amyloid Goiter: A Case Series
por: Paz-Ibarra, Jose, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_2pm0f9rd5meujj12n4qvlpp0nv